Phantom Limb Pain in Amputees After the 2023 Türkiye Earthquake
NCT ID: NCT06617728
Last Updated: 2024-10-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
39 participants
OBSERVATIONAL
2023-02-06
2024-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
What is the prevalence of phantom limb pain among earthquake-related amputees at different follow-up intervals? How do different pain management strategies, such as regional analgesia versus intravenous analgesia, affect the severity and persistence of phantom limb pain? Researchers will compare participants receiving regional analgesia to those receiving intravenous analgesia to see if regional techniques are associated with lower rates of phantom limb pain and improved quality of life.
Participants will:
Complete pain assessments using standardized questionnaires at 1 week, 3 months, 6 months, and 12 months post-amputation.
Provide information on their pain management experiences and the impact on their daily activities.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Our Emergency Fasciotomy and Amputation Experiences
NCT06764446
Sagittal Spinopelvic Parameters in Patients With Lower Extremity Amputation
NCT05318508
Comparison of Different Amputation Levels
NCT04330274
Extremity Thermographic Values in Individuals With Transtibial Amputation
NCT06258343
Relationship Between Prosthesis Adaptation and Functional Mobility
NCT06827119
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients were recruited from those treated at Mersin University Hospital immediately following the earthquake. Inclusion criteria included individuals aged 5 years and older who experienced amputation due to earthquake-related trauma. Exclusion criteria included pre-existing psychiatric disorders, history of neuropathic pain in the amputated limb, or inability to communicate due to cognitive impairment.
The study's primary outcomes are the prevalence of PLP and PLS at 1 week, 3 months, 6 months, and 12 months post-amputation. Pain intensity is measured using the Visual Analog Scale (VAS), and the impact of different analgesic techniques on pain severity and quality of life is analyzed. Secondary outcomes include the incidence of residual limb pain and the effectiveness of various pain management strategies in reducing pain symptoms over time.
This study is expected to contribute valuable insights into the management of PLP in disaster-related amputees, providing evidence to guide clinical practice and improve patient outcomes in similar post-disaster settings.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1: Regional Analgesia Cohort
Participants receiving regional analgesia for pain management.
Intervention 1: Regional Analgesia
Regional analgesia techniques like epidural or peripheral nerve blocks.
Group 2: Intravenous (IV) Analgesia Cohort
Participants receiving IV analgesia for pain management.
Intervention 2: Intravenous (IV) Analgesia
IV medications used for pain control, including opioids and non-opioid analgesics.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention 1: Regional Analgesia
Regional analgesia techniques like epidural or peripheral nerve blocks.
Intervention 2: Intravenous (IV) Analgesia
IV medications used for pain control, including opioids and non-opioid analgesics.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who have undergone amputation due to injuries sustained during the 2023 Türkiye earthquake.
* Experiencing phantom limb pain (PLP) as confirmed by a structured questionnaire.
* Able to provide informed consent or have consent provided by a legal guardian if under the age of 18.
Exclusion Criteria
* History of neuropathic pain in the amputated limb prior to the earthquake.
* Underwent surgical interventions in other parts of the body that may affect pain assessment.
* Inability to communicate effectively due to cognitive impairment or other medical conditions.
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mesut Bakır
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mesut Bakır
Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mesut Bakır, Assoc. Prof
Role: STUDY_CHAIR
Mersin University Faculty of Medicine, Pain Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mersin University Faculty of Medicine
Mersin, Yenişehir, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TURK-PLP-2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.